---
kind: "section"
citation: "40 C.F.R. § 721.305"
title: "40"
number: "721.305"
heading: "Di-substituted acetophenone (generic)."
url: "https://uscodex.org/cfr/40/721.305"
---

# §721.305. Di-substituted acetophenone (generic).

- (a) **Chemical substance and significant new uses subject to reporting.**
  - (1) The chemical substance identified generically as di-substituted acetophenone (PMN P-97-93) is subject to reporting under this section for the significant new uses described in [paragraph (a)(2)](#a-2) of this section.
  - (2) **The significant new uses are—**
    - (i) **Protection in the workplace.** Requirements as specified in § [721.63 (a)(1)](/cfr/40/721.63.md?p=a-1), [(a)(2)(i)](/cfr/40/721.63.md?p=a-2-i), [(a)(2)(ii)](/cfr/40/721.63.md?p=a-2-ii), [(a)(2)(iii)](/cfr/40/721.63.md?p=a-2-iii), [(a)(3)](/cfr/40/721.63.md?p=a-a-3), [(b)](/cfr/40/721.63.md?p=a-a-b) (concentration set at 1.0 percent), and (c).
    - (ii) **Hazard communication program.** Requirements as specified in § [721.72 (a)](/cfr/40/721.72.md?p=a), [(b)](/cfr/40/721.72.md?p=b), [(c)](/cfr/40/721.72.md?p=c), [(d)](/cfr/40/721.72.md?p=d), [(e)](/cfr/40/721.72.md?p=e) (concentration set at 1.0 percent), (f), (g)(2)(i), (g)(2)(v). The following statement shall appear on each label as specified in [§ 721.72(b)](/cfr/40/721.72.md?p=b) and the SDS as specified in [§ 721.72(c)](/cfr/40/721.72.md?p=c): This substance is expected to be dermally absorbed and may cause effects to the liver, kidney, adrenal glands, and the heart.
    - (iii) **Industrial, commercial, and consumer activities.** Requirements as specified in [§ 721.80(q)](/cfr/40/721.80.md?p=q).
- (b) **Specific requirements.** The provisions of subpart A of this part apply to this section except as modified by this paragraph.
  - (1) **Recordkeeping.** Recordkeeping requirements as specified in § [721.125 (a)](/cfr/40/721.125.md?p=a), [(b)](/cfr/40/721.125.md?p=b), [(c)](/cfr/40/721.125.md?p=c), [(d)](/cfr/40/721.125.md?p=d), [(e)](/cfr/40/721.125.md?p=e), [(f)](/cfr/40/721.125.md?p=f), [(g)](/cfr/40/721.125.md?p=g), [(h)](/cfr/40/721.125.md?p=h), and [(i)](/cfr/40/721.125.md?p=i) are applicable to manufacturers, importers, and processors of this substance.
  - (2) **Limitations or revocation of certain notification requirements.** The provisions of [§ 721.185](/cfr/40/721.185.md) apply to this section.
  - (3) **Determining whether a specific use is subject to this section.** The provisions of [§ 721.1725(b)(1)](/cfr/40/721.1725.md?p=b-1) apply to this section.

## Notes

### Amendments

[63 FR 44574, Aug. 20, 1998]

### Authority

Authority: 15 U.S.C. 2604, 2607, and 2625(c).

### Source

Source: 49 FR 35018, Sept. 5, 1984, unless otherwise noted.

### Amendments

[63 FR 44574, Aug. 20, 1998]